-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
March 01, 2020 - Introduction
Anticoagulants are a critical therapy in the prevention and treatment of various types … Dabigatran versus Warfarin in the treatment of acute
venous thromboembolism. … Oral rivaroxaban for the treatment of symptomatic pulmonary
embolism. … Weight-based argatroban dosing nomogram for treatment of
heparin-induced thrombocytopenia. … The mean time of the INR in therapeutic range
(TTR) was 62.75%.
-
www.ahrq.gov/research/findings/ta/index.html
May 01, 2025 - Ventilators (2017; PDF - 144 KB) Catheter Ablation for Atrial Fibrillation (2014; PDF - 216 KB) Therapeutic … Options for Obesity in the Medicare Population (2014; PDF - 316 KB) Pain Management Injection Therapies
-
www.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-reimagining-healthcare-teams-2.html
July 01, 2023 - a patient’s history or to consider all potential data points to develop high-quality diagnostic or therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Hurley_55.pdf
March 07, 2008 - The grant supported the creation of the Community Anticoagulation Therapy (CAT)
Clinic and the Cedar … These two practices manage approximately 2,000 patients on long-term warfarin
therapy, representing … Therefore, almost 40 percent of the variation in a patient’s therapeutic range (typical therapeutic … Repeat INR determinations would be made until the patient was back in therapeutic range. … Bleeding
and thromboembolism during anticoagulant therapy:
A population-based study in Rochester, Minnesota
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-ger.pdf
June 02, 2025 - to distinguish between physiologic and pathologic GER
(GERD, or GER disease) before beginning any therapeutic … Treatment
■ Medical or surgical therapy is indicated only for pathological GER. … ■ Therapies may improve symptoms, but generally reflux is not entirely eliminated.
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-164-materials-ii.pdf
June 02, 2025 - Services and Codes, by Severity
Treatment Variables Definition – by Severity
Variable Proc. … Partial Pulpectomy
D7210, D7220,
D7230, D7240
Complete Pulpectomy
D3120 Pulp Cap Indirect
D3220 Therapeutic … Pulpotomy
D3240 Pulpal therapy Posterior Primary
D3310 , D3320,
D3330
End Therapy (Root Canals), Anterior … Bicuspid and Posterior
Tooth
ENDODONTICS D3120 Pulp Cap Indirect
D3220 Therapeutic Pulpotomy
D3240 … Pulpal therapy Posterior Primary
End Therapy (Root Canals), Anterior Bicuspid and Posterior
Tooth
-
www.ahrq.gov/research/findings/final-reports/stpra/stpraapbfig3.html
April 01, 2018 - and cataract procedures—30 percent
Excision of semilunar cartilage of the knee—8 percent
Other therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/improve/program-part1-slides.pptx
November 01, 2019 - trends
Assists with some AS interventions (non-stewardship pharmacists)
IV to oral conversion protocols
Therapeutic … antibiotic monitoring protocols
Pharmacy and Therapeutics
(P&T)
Committee Decisions regarding formulary … Adverse event detection
Appropriate microbiology specimen collection
Timing of therapeutic drug level … Antibiotic Decision Making approach
Diagnostic criteria for infection
Appropriate cultures and empiric therapy … The ASP should develop guidelines for management and treatment of common infectious diseases syndromes
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Emanuel-Berwick_110.pdf
July 02, 2008 - simple
and overarching model identifies four domains of patient safety (recipients of care, providers,
therapeutics … In an important parallel development, as treatments became increasingly effective, the medical
field … The practitioner was trained and certified to apply
therapy at the point of the illness-causing disorder … Misuse was further defined as the
preventable complications of treatment. … The nature of the illnesses and social setting, the nature of the
therapies, the nature of the human
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-apnea.pdf
June 02, 2025 - center in the immature brain stem does not trigger inspiration;
frequently responds to methylxanthine treatment … Home Treatment
■ Most infants still having apnea are kept hospitalized; few may be discharged home. … – Caffeine is most commonly used due to its broader therapeutic index and slower
excretion rate than … Infants are generally monitored for a 5- to 7-day apnea-free period after discontinuing
methylxanthine therapy
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_T1-Concise_Antibiogram_Toolkit_Background.pdf
May 01, 2014 - nursing homes in creating their own antibiograms, an important
tool for guiding empiric antimicrobial therapy … susceptibility test data reports to determine the most appropriate agents for
initial empirical antimicrobial therapy … practitioners, and physician assistants—can consult these
tools before initiating empiric antibiotic therapy … Selection of empiric therapy in a particular patient should not be based solely on an
antibiogram … including patient characteristics and prevalence of other risk factors should be
incorporated when making therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_T1-Concise_Antibiogram_Toolkit_Background.doc
May 01, 2014 - nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy … susceptibility test data reports to determine the most appropriate agents for initial empirical antimicrobial therapy … practitioners, and physician assistants—can consult these tools before initiating empiric antibiotic therapy … · Selection of empiric therapy in a particular patient should not be based solely on an antibiogram … including patient characteristics and prevalence of other risk factors should be incorporated when making therapeutic
-
www.ahrq.gov/research/findings/final-reports/stpra/stpraapb.html
April 01, 2018 - Excision of semilunar cartilage of knee
67,742
2.38%
38,074
2.06%
29,668
2.95%
Other therapeutic … Inguinal and femoral hernia repair
48,674
1.71%
40,790
2.21%
7,884
0.78%
Other OR therapeutic
-
www.ahrq.gov/funding/grantee-profiles/grtprofile-malone.html
September 01, 2023 - The University had received a grant from the AHRQ Centers for Education and Research on Therapeutics … Specifically, he held focus groups with hospital pharmacy and therapeutic (P&T) committee members—whose
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
March 01, 2015 - ● Antipsychotic medications are among the most expensive, highest in risk, and fastest growing of therapeutic … Academy
of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental Health
Therapeutics … The next measure encourages use of psychosocial intervention as a first-line
treatment for children … Two measures assess receipt of services for children
and adolescents who initiate antipsychotic treatment
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/iadapt/yelin.pdf
December 19, 2014 - Project Aims
The project aims were to:
1) Assess current knowledge of therapeutic options in
-
www.ahrq.gov/sites/default/files/2024-01/lambert2-report.pdf
January 01, 2024 - Final Progress Report: UIC Center for Education and Research on Therapeutics Tools for Optimizing Prescribing … Emphasis
centers on the quality of the available evidence and on comparisons to therapeutic alternatives … specified the use of actual body weight for dosing and trough serum concentrations at steady
state for therapeutic … The use of anticoagulant therapy for the prevention and treatment of venous
thromboembolism (VTE) and … being used as a mechanism to switch otherwise reluctant patients from expensive
to less expensive therapies
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA116-Materials-II.pdf
June 02, 2025 - Documentation child was eligible for and received therapeutic
hypothermia (when appropriate). … EXCLUDE if identification of
eligibility and plan for therapeutic hypothermia were in place within
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T1-Background_final.docx
October 01, 2016 - susceptibility test data reports to determine the most appropriate agents for initial empirical antimicrobial therapy … practitioners, and physician assistants—can consult these tools before initiating empiric antibiotic therapy … Antibiograms are not generalizable to different nursing homes; they can be useful tools for guiding empiric therapy … monitoring antibiotic susceptibility trends within a specific nursing home.
· Selection of empiric therapy … including resident characteristics and prevalence of other risk factors should be incorporated when making therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK1_T1-Background_final.pdf
October 01, 2016 - susceptibility test data reports to determine the most appropriate agents for initial empirical
antimicrobial therapy … practitioners, and physician assistants—can consult these tools
before initiating empiric antibiotic therapy … Antibiograms are not generalizable to different nursing homes; they can be useful tools for
guiding empiric therapy … • Selection of empiric therapy in a particular resident should not be based solely on an antibiogram … resident characteristics and prevalence of other risk factors should be incorporated when making
therapeutic